Semaglutide has been proven to bring about medullary thyroid cell carcinoma in rodents. Though its medical relevance to people is unidentified, the FDA advises not to administer this drug in These with a private or family record of medullary thyroid carcinoma. Semaglutide also poses a chance of pancreatitis and dehydration.para reducir el riesgo de